A novel enzymatic ‘digital to biological converter’ approach to DNA and mRNA synthesis empowers biotech companies to create molecules on-site without waiting for an external service provider ...

This conversion is called A-to-I mRNA editing. Proteins in the cell called ADAR are responsible for it. ... more than 26,000 sites transcribed from its DNA into mRNA undergo A-to-I mRNA editing.

Cell-Free DNA: Accelerating Next-Gen mRNA Therapeutics. Combining AI-driven design with rapid, cell-free DNA synthesis, researchers are turning mRNA into a scalable solution for vaccines, cancer ...